We report here the second evidence of retrotransposition of L1, which was found inserted into the dystrophin gene of a patient, causing Duchenne muscular dystrophy (DMD). When the PCR was used to amplify a region of the dystrophin gene encompassing exon 44 from genomic DNA of two Japanese brothers with DMD, it was found to be -600 bp larger than expected. Both the normal and the abnormally large products were amplified from the DNA of their mother. However, the maternal grandparents did not have the abnormal allele, and the mutation must therefore have occurred in the mother. Analysis of nucleotide sequence of the amplified product from a patient disclosed that the insertion was present zero to two bases upstream from the 3' end of exon 44 and that two to four bases of the exon sequence were deleted from the insertion site. The insertion sequence was found to be composed of 606-608 bp and to be almost identical to the inverse complement of 3' portion of the Li retrotransposon consensus sequence. The dystrophin gene transcript from peripheral lymphocytes of one of the patients was analyzed by using reverse transcription/ semi-nested PCR. The size of the amplified product encompassing exon 42 to 46 was smaller than expected. Sequencing of the amplified product disclosed that the sequence of exon 43 was directly joined to that of exon 45. Exon 44 of the transcript was thus shown to be skipped during splicing. This novel mutation of the dystrophin gene has important implications regarding retrotransposition of an active Ll element and provides a new insight into the origins of mutations in the dystrophin gene. (J.
gene, which is spread over 2,500 kb of the X chromosome. A large proportion of mutations are partial gene deletions or duplications (60 and 6-10% of the total, respectively) of varying sizes (1) (2) (3) . Results of gene analyses show that in > 90% of cases, mutations that maintain the reading frame in the dystrophin transcript cause BMD, while those in which a frameshift has occurred cause DMD (4) . Recently, we found that determination of translational reading frame by analyzing dystrophin mRNA is far more reliable than gene analysis for the diagnosis of DMD/BMD because exon skipping during splicing resulting from deletion ofa very small segment ofexon sequence has been demonstrated to occur in dystrophin Kobe (5) .
DMD is frequent (1 per 3,500 live male births), and it has been estimated that one third ofDMD/BMD cases result from new mutations of the dystrophin gene (6) . However, other than its large size, there is no obvious explanation for the apparently abnormally high rate of mutations in the dystrophin gene. The dystrophin gene has been shown to have two mutation hot spots, but they appear to be devoid of features that might render them susceptible to mutation ( 1) .
L1 elements are a family of long, interspersed, repetitive DNA sequences that are present at 105 copies (full length and truncated) dispersed throughout the genome. The human full-length Ll element comprises 6.1 kb, and contains two long open reading frames (ORFs), the second of which could encode a polypeptide having sequence similarity to reverse transcriptases, and a polyadenylation signal followed by poly (A) tract. The majority of LI elements are truncated at their 5' end and have premature stop codons in the ORF. Most of the elements have flanking target site duplications of 5 to 15 bases. These structural characters suggest that L1 elements are capable of transposition by way of an RNA intermediate (7) . Evidence that some LI elements in the human genome are retrotransposable was provided by de novo transposition of a truncated LI DNA into exon 14 of the Factor VIII gene on the X chromosome in two individuals (8) . Each new insertion contained the 3' portion of an Ll element, including much of the second open reading frame of the consensus sequence and a poly(A) tract, and was flanked by a perfect target site duplication. From its unique 3' trailing sequence, the inserted sequences have been assigned to a subtype of LI family (9) . In addition, a full-length Ll element considered to be a progenitor ofthe inserted sequence was identified on chromosome 22 (10) and shown to have retrotranscriptase activity ( 11) . 
Results
We have previously screened for deletion mutations in the dystrophin gene by using PCR (13, 16) . Nine exons distributed throughout the deletion-prone region of the dystrophin gene have been amplified from genomic DNA from over 200 Japanese patients with DMD/BMD. In the cases discussed here, agarose gel electrophoresis did not reveal the presence of an amplified product of the expected 268 bp fragment encompassing exon 44, which was apparently replaced by a larger amplified product (Fig. 2 , lanes 4 and 5). All other amplified exons were of the normal size. These results indicated the presence of an insertion mutation in the amplified region. To determine the location of the insertion more precisely, the oversized frag- Insertion of an LI Element into the Dystrophin Gene 1863 ment was amplified as two separate parts using primers both complementary to central region of exon 44 sequence and based on 5' end of exon 44 (Fig. 1 a) . The amplified product encompassing intron 43 to the middle of exon 44 was as large as expected ( 106 bp), while the amplified product encompassing the 5' end ofexon 44 to intron 44 was -600 bp larger than the normal product (-850 bp vs 236 bp) (data not shown). These results indicated that an insertion was present in the boundary region of exon 44 and intron 44.
To determine the inheritance of this mutation, the exon 44-encompassing fragment was also amplified from genomic DNA obtained from the mother and from the maternal grandparents. Two different products were amplified from the mother's DNA: one corresponding to the normal product and the other corresponding to the product amplified from the DNA of her sons (Fig. 2, lane 3) . This indicated that the mother is a carrier of this mutation. Only the normal-sized fragment was amplified from DNA from the maternal grandparents (Fig. 2, lanes I and 2) . All amplified products corresponding to normal fragments could be cut into two segments by restriction enzyme AflII (data not shown). These results indicated that the maternal grandparents had only normal allele and that the insertion mutation originated in the mother.
To characterize the insertion mutation further, the larger fragment amplified from the elder brother was sequenced. The nucleotide sequence ofthe 5' portion ofthe fragment was completely homologous to that of the boundary region between intron 43 and exon 44 of the dystrophin gene up to nucleotide 6642 of dystrophin cDNA (Fig. 3) . The region immediately downstream from nucleotide 6642 was completely different from that of the wild-type sequence, and contained a 606-bp long insertion starting with a C followed by 18 successive T nucleotides. Sequences homologous to the last two nucleotides of 3' end of exon 44 sequence (nucleotides 6645 and 6646 of dystrophin cDNA) and the sequence of intron 44 were identified after the end of the insertion sequence (Fig. 3) By screening DNA sequence data banks, the inserted sequence was found to be 98% identical to the inverse complement of the 3' portion (nucleotides 5563 to 6161) of the consensus genomic sequence of the L1 element (named L1.HS) (17) (Fig. 4) . Although some nucleotides of the insertion in dystrophin Yakumo (Ll.DY) differed from the consensus sequence, the 3' portion of the second ORF was conserved. LL.DY has a poly (A) tract preceded by a polyadenylation signal (AATAAA), but has an additional seven successive A nucleotides and one G nucleotide downstream of the 3' end of the region that is highly homologous to LI.HS (Fig. 4) . Among the 598 nucleotides that are homologous to the consensus LI sequence, nine nucleotides of LL.DY differ from those in L1.HS. However, eight of these nine nucleotides are same as those in consensus L1 cDNA sequence (18) . The sole difference between LL.DY and this cDNA consensus is the A to G transition at nucleotide 5823 (Fig. 4) . Ll elements can be subtyped according to the sequence ofthe 3' trailing region, and a consensus sequence has also been proposed for this region from the analysis of 20 randomly selected human genomic LI elements (9). L1 .DY has exactly same nucleotide sequence as the cDNA of the Ta subset of LI elements ( 18) . All of these data strongly suggest that retrotranscriptional insertion of an active LI occurred very recently in the dystrophin gene.
As the insertion sequence in dystrophin Yakumo was found to be a 5' truncated L1 element, and the two nucleotides at the 3' end ofthe inserted element are the same as those at the 5' end of the target site of exon 44 (Fig. 3) , the insertion sequence might be two bases longer (608 bp), and four nucleotides ofthe 3' end of exon 44 might have disappeared from the target site. In this extreme case, none ofthe exon 44 sequence is left at the 5' end of disrupted dystrophin gene.
It is very important to determine the effect of mutations on the translational reading frame for the diagnosis of DMD/ BMD. For this purpose, an illegitimate transcript ofthe dystrophin gene in peripheral lymphocytes has been used to determine the reading frame ofdystrophin transcript in muscle cells (19) . In this study, we analyzed the dystrophin transcript around exon 44 region by amplifying a region encompassing exons 42-46 on dystrophin cDNA (Fig. 1 b) . A 583 bp long product was amplified from the normal transcript by seminested PCR (Fig. 5, lane 1) , while an -600-bp longer fragment was expected to be amplified from cDNA prepared from lymphocytes of the elder brother. Instead, the amplified prod- (Fig. 6 ). This indicated that exon 44 of the patient's dystrophin gene was skipped during splicing ofthe mRNA precursor. The translational reading frame of the dystrophin gene was thereby shifted by 2 bases and a stop codon appeared at codon 2182 (Fig. 6 ). Considering that patients were suffering from DMD, this truncated dystrophin transcript was probably the main in situ spliced product in muscle cells.
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Discussion
Evidence for the contemporary movement ofan L I element in humans was first obtained in cases of hemophilia A that resulted from de novo insertion of an Ll element into Factor VIII gene (8) . The structural characteristics of LI elements indicate that they can amplify themselves by a cycle of transcription, reverse transcription, and integration in germline cells or in cells designated to become germlines. By using the largest L1 element inserted into Factor VIII gene as a probe, Dombroski et al. were able to find a full-length LI element (named Ll .2) that is considered to be a progenitor of the LI element inserted into Factor VIII gene, and to map it on chromosome 22 (10). Furthermore, it was shown that the protein encoded by LI.2 has reverse transcriptase activity ( 11) . These findings support a self-propagation model for the spread of the LI element through the human genome (10) .
Dystrophin Yakumo described here is the second example of the disruption of a human gene induced by the insertion of an LI element. The mutation is considered to be a fairly rare and relatively recent event, since the insertion ofan Ll element into the dystrophin gene was found only in this family among > 200 Japanese families of dystrophy patients screened. The insertion event was found to have occurred in the mother (Fig.  2) . The LI element found in dystrophin Yakumo (Ll.DY) was 98% homologous to 5' truncated consensus L1 element (Fig. 4) . The inserted sequence has the following characteristics: (a) The insertion occurred in an A + T rich region of the dystrophin gene. (b) L 1.DY retains the ORF for retrotranscriptase, although it is truncated at the 5' end, and has a polyadenylation signal at its 3' end followed by poly (A) tract (Fig. 4) . (c) L1.DY differs by only one nucleotide from the consensus sequence ofa subtype of LI which is known to be active retroposon ( 10) .
In dystrophin Yakumo, the poly (T) tail of LI cDNA may be involved in base-pairing with the A-rich dystrophin sequence after the introduction ofstaggered single-strand breaks. This break may have occurred at the palindromic structure that includes the Afl I restriction enzyme recognition site. However, sequencing of genome showed that gap repair occurred, causing the loss of least two nucleotides of dystrophin sequence (Fig. 3) . In addition, one G nucleotide was detected at the end ofpoly (A) tract (Fig. 4) . A guanosine is known to be present in this position in the probable progenitor ofL1.2 ( 10) . Therefore, the last G nucleotide in Ll.DY may be transcribed from the flanking sequence of the progenitor element. This suggests that the poly (A) tract was not added after transcription, but is rather transcribed from the genomic element.
One ofthe most intriguing findings reported here is that the insertion of L1 .DY did not create a target site duplication (Fig.  4) , which is considered to be one of the hallmarks of retroposons. However, the absence of target site duplications has been described for some other L 1 elements (20) .
The results of the study presented here suggest that at least trailing regions, LI elements have been divided into several subtypes (9) . The active LI element L 1.2 ( 10) has almost same sequence in the 3' trailing region as the consensus sequence of LI cDNA. The 3' trailing region ofthe LL.DY element is completely homologous to that of Li.2. This strongly suggests that Li.DY also originated from the same progenitor sequence as that which gave rise to the sequences inserted into Factor VIII gene (8) .
Differing from germline cells, the LI element has been reported to be functionally active in neoplastic cells (2 1 (23) .
Exon skipping during splicing of mRNA precursors has been reported in some genomic mutations. The primary effect of almost every mutation which induces exon skipping during splicing is to change the consensus splicing sequence. This is not the case with dystrophin Kobe, however, which has a deletion mutation near the 3' end of exon 19 . We have shown that exon 19 of the dystrophin transcript is skipped during splicing even though the consensus splicing sequence is unaffected (5). In dystrophin Yakumo, exon 44 of the dystrophin transcript was found to be skipped during splicing (Fig. 6) , indicating that the original 5' splicing donor site ofintron 44 ofthe dystrophin gene was inactivated because of the LI insertion in the 3' end of exon 44. In one-third of mutations with 5' splice site inactivation, activation ofcryptic splice sites has been reported (24) . The insertion mutation ofdystrophin Yakumo created a sequence of CAGGTTAGT, which had only one nucleotide difference from the consensus sequence (CAGGTAAGT) (25) , at 57 bp downstream of the insertion site. Though this was supposed to be a candidate sequence for splice donor site, no amplified product corresponding to this splice site was obtained from dystrophin cDNA prepared from lymphocytes (Fig. 5, lane 2) . This suggest that factors other than a nucleotide sequence may determine the splice donor site (26, 27) .
In dystrophin Yakumo, the consensus sequence for the 5' splice donor site has been displaced to -600 bp downstream from its original site due to the insertion mutation. As a result, an A nucleotide located 5' end of the consensus splicing sequence was replaced by a T, but this change is not considered to be critical for splice site recognition (25) . According to the model for exon recognition, the size of exon is at most 300 bp (27) ; the length of exon 44 with the insertion mutation (754 bp) is considerably larger. Therefore, the exon may not be recognized by the splicing machinery and therefore is skipped. Although the dystrophin transcript in lymphocytes is considered to be spliced in the same way as in muscle cells, further studies are needed to examine splicing in muscle cells from the dystrophin Yakumo. Unfortunately, this cannot be done because most of the patients' muscle have been replaced by connective and fatty tissues. Furthermore, we need to determine whether cryptic splice site activation occurs as a result of this mutation, as has been reported in some other exon skipping cases (28, 29) .
By using in situ hybridization, the LI family of retrotransposons was found to be present dominantly in Giemsa/Quinacrine-positive bands of chromosomes which are rich in A + T residues (30) . LI elements have been reported to be present in intron sequences of the dystrophin gene approximately every 30 kb (31 ) . In the present paper we report that the dystrophin gene is a target for LI insertion. From (34) . (e) Homologous recombination between Alu sequences, the other repetitive sequence ofthe human genome, have been shown to result in the deletion of a receptor gene coding for low density lipoprotein (35) . Further studies are needed to test this hypothesis for the origin of mutations in the dystrophin gene.
